Washington, DC - Today, Congressman Michael McCaul (TX-10), founder and co-chair of the Childhood Cancer Caucus, and Representatives Jackie Speier (D-CA), Mike Kelly (R-PA), and G. K. Butterfield (D-NC) introduced the Childhood Cancer STAR (Survivorship, Treatment, Access, and Research) Reauthorization Act.

"The STAR Act is the most comprehensive childhood cancer bill ever considered before Congress and has been instrumental in boosting research that addresses major concerns facing the pediatric cancer community," Rep. McCaul said. "Protecting the lives of our children continues to be a priority, and I am hopeful the STAR Act is reauthorized so it may continue to save young lives."

“Childhood cancer is a nightmare no child or parent should ever have to experience, and even with cure rates for children diagnosed with cancer increasing to 85 percent, many survivors continue to face the unexpected nightmare of ongoing pain, disability, and medical needs stemming from treatment,” Rep. Speier said. “The population of childhood cancer survivors is estimated to be over half a million people today, making the care and quality of life issues these brave survivors grapple with all the more critical. The 2018 STAR Act was the most comprehensive bipartisan childhood cancer bill ever signed into law and I’m proud to continue building on its life-saving initiatives with the STAR Act reauthorization. As we fight for funding for research to beat this insidious disease, we must ensure that survivors not only live but thrive.”

“Every year in North Carolina and across the country, we lose far too many young people to childhood cancers. It is crucial that we continue to fund pediatric cancer research and child-focused cancer treatments to support our young people and help ensure that they can lead healthy, productive lives,” Rep. Butterfield said. “The STAR Act has been critical to those efforts and has resulted in over $270 million in new childhood cancer funding in the past four years. I am proud to join my fellow Childhood Cancer Caucus co-chairs in introducing the Childhood Cancer STAR Reauthorization Act to continue these important programs for another five years.”

“I’m proud to once again support and lead the STAR Act, which has proven its immense value since it was first passed in 2018. Our children are our future, and it’s our duty to fund the research that will protect them in their most vulnerable moments and to ultimately find a cure. I’m hopeful that Congress will prioritize this research and reauthorize the STAR Act,” Rep. Kelly said.

The STAR Act was a major step for childhood cancer research. After it was signed into law by President Trump in 2018, it expanded opportunities for childhood cancer research, improved efforts to identify and track childhood cancer incidences, and enhanced the quality of life for childhood cancer survivors. The Childhood Cancer STAR Reauthorization Act of 2022 will allow programs included in the successful STAR Act to continue for the next five years.